Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics
Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics
批准号:
8378111
负责人:
Patrick Robert Griffin
金额:
$59.53万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AgonistAnimal ModelAutomobile DrivingBioavailableBiological AssayBiological AvailabilityBiosensorBrainButyric AcidsCalciumCell LineCellsCessation of lifeChemicalsClinicalComputer SimulationComputer softwareCoupledCyclic AMPDataDevelopmentDoseDrug AddictionDrug InteractionsDrug KineticsDrug or chemical Tissue DistributionDrug toxicityDyesEvaluationExposure toGABA AgonistsGABA-B ReceptorGoalsHepaticHourHousingImageIn VitroLaboratoriesLeadLiverMeasuresMethodologyMethodsMonitorNeuronsNicotine DependenceOralPenetrationPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyPhosphorylationPropertyProtocols documentationRattusReaderRecombinantsResearchResearch Project GrantsSeriesSolubilityTestingTherapeutic InterventionTimeTissuesTobacco smokingTriagebasecheminformaticscomputational chemistrycomputerized toolscounterscreencyclic-nucleotide gated ion channelsdrug candidatedrug metabolismfeedinggamma-Aminobutyric Acidin vitro Assayin vivoin vivo Modelnovelpharmacokinetic modelprofessorprogramsreceptorresidencesmall moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In vitro functional characterization of GABA_B receptor modulators: The emphasis of this research project is on developing novel cell-based assays suitable to determine potency of GABA_B receptor modulators, counterscreens to assess selectivity of high priority potent modulators, functional assays to elucidate in vitro pharmacology of compounds, in vitro and in vivo drug metabolism screens, and development of cheminformatic approaches for rapid hit expansion and evaluation of chemical space. GABA_B receptor modulators that are synthesized in the laboratory of Professor MG Finn (PI of TSRI La Jolla research project) will be characterized in the aforementioned assays. Compounds with appropriate in vitro potency and pharmacology will be tested for solubility, liver microsomal stability, and in vivo pharmacokinetic properties. Compounds with acceptable in vitro profiles and with adequate in vivo PK properties will be evaluated using in vivo models in Professor Athina Markou's laboratory (PI). Iterative chemical optimization will be employed and supplemented with in silico hit expansion approaches resulting in potent and selective GABA_B modulators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
-
批准号:10503840
-
项目类别:
-
资助金额:$59.28万
-
财政年份:2022
-
负责人:Patrick Robert Griffin
-
依托单位:
Quantifying and modeling ligand-dependent control of RORγ dynamics via structural proteomics
-
批准号:10704173
-
项目类别:
-
资助金额:$59.28万
-
财政年份:2022
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10426408
-
项目类别:
-
资助金额:$2.64万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10317378
-
项目类别:
-
资助金额:$67.81万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
PPARG regulates osteocyte bioenergetics and function during aging
-
批准号:10634739
-
项目类别:
-
资助金额:$66.56万
-
财政年份:2021
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9926588
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:9899246
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10357876
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10115706
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
Small molecules targeting hepatic glucose production and insulin resistance
-
批准号:10581523
-
项目类别:
-
资助金额:$65.02万
-
财政年份:2019
-
负责人:Patrick Robert Griffin
-
依托单位:
ALDH1a1 Inhibition As A Therapeutic Target In Visceral Adiposity and Type 2 Diabetes
-
批准号:10197108
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2017
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9526730
-
项目类别:
-
资助金额:$62.22万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9764509
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Developing nonmuscle II inhibitors for substance use relapse
-
批准号:9125423
-
项目类别:
-
资助金额:$63.84万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
-
批准号:9244000
-
项目类别:
-
资助金额:$43.92万
-
财政年份:2016
-
负责人:Patrick Robert Griffin
-
依托单位:
Optimization of ERRg-specific ligands as in vivo Chemical Probes
-
批准号:9382901
-
项目类别:
-
资助金额:$39.84万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Molecular Characterization of Novel Insulin Sensitizers
-
批准号:9087254
-
项目类别:
-
资助金额:$58.27万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Development of RORbeta-selective modulators as in vivo probes
-
批准号:9088532
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
Molecular Characterization of Novel Insulin Sensitizers
-
批准号:8986841
-
项目类别:
-
资助金额:$60.57万
-
财政年份:2015
-
负责人:Patrick Robert Griffin
-
依托单位:
HDX and NMR Core
-
批准号:10242903
-
项目类别:
-
资助金额:$104.57万
-
财政年份:2012
-
负责人:Patrick Robert Griffin
-
依托单位:
海外基金